Tag

Hpv Vaccine

All articles tagged with #hpv vaccine

US HPV Vaccine Guidelines Face Legal and Medical Crossroads Over Single-Dose Debate
health10 days ago

US HPV Vaccine Guidelines Face Legal and Medical Crossroads Over Single-Dose Debate

US HPV vaccination guidance is in flux as the American Academy of Pediatrics (AAP) considers adopting a single-dose schedule, mirroring a controversial move by HHS Secretary Robert F. Kennedy Jr. that is currently blocked by a federal court. While recent trials in Costa Rica show one dose offers 97% protection against cervical cancer in girls, experts warn that data for boys and other cancers remains limited. Despite the debate, vaccination rates have stagnated for four years, with only 63.4% of teens fully vaccinated.

Global Study: Infections Cause 12% of New Cancers, Highlighting Preventable Risks
health13 days ago

Global Study: Infections Cause 12% of New Cancers, Highlighting Preventable Risks

A new study in The Lancet Oncology estimates that 2.3 million new cancer cases worldwide in 2024, or 12% of all diagnoses, were caused by infectious agents. The five most significant pathogens are Helicobacter pylori, human papillomavirus (HPV), hepatitis B, Epstein-Barr virus, and hepatitis C. Researchers emphasize that many of these cancers are preventable through vaccination, screening, and treatment, though access to these interventions remains uneven globally.

HPV Vaccine’s Protective Reach Extends to Men, Reducing Head and Neck Cancers
health1 month ago

HPV Vaccine’s Protective Reach Extends to Men, Reducing Head and Neck Cancers

An observational US study finds that the HPV vaccine, originally aimed at preventing cervical cancer in women, is associated with about a 70% lower incidence of head and neck cancers in men, especially oropharyngeal cancer. While not yet proving causation, the data suggest broad cancer-prevention benefits and reinforce the push for gender-neutral HPV vaccination beyond protecting cervical cancer.

HPV Vaccine Could Have Prevented 3 Cancers, Woman Urges Vaccination
health2 months ago

HPV Vaccine Could Have Prevented 3 Cancers, Woman Urges Vaccination

A Tampa Bay Times report chronicles Eileen McGill Fox’s fearlessly public story: routine HPV screening identified high-risk HPV, which contributed to vulvar, cervical, and anal cancers over several years, and doctors say the HPV vaccine could have prevented much of her treatment. She is now advocacy-focused, urging vaccination and regular screening to prevent HPV-related cancers and reduce stigma.

Snooki Breaks Silence After Cervical Cancer Surgery: Hope, Fear, and Pap Smears
health2 months ago

Snooki Breaks Silence After Cervical Cancer Surgery: Hope, Fear, and Pap Smears

Nicole “Snooki” Polizzi posted an emotional update about her hysterectomy for Stage 1 cervical cancer, describing the fear ahead of surgery and noting that doctors removed her uterus and cervix (and parts of the vagina) to ensure all cancer was removed, while urging viewers to get regular Pap tests and focusing on recovery with hope for a cancer-free outcome.

Pittsburgh video sparks national push to rebuild vaccine trust
health2 months ago

Pittsburgh video sparks national push to rebuild vaccine trust

A 2017 viral video by Pittsburgh pediatricians promoting the HPV vaccine sparked a massive online anti-vaccine backlash, drawing messages from thousands of posts worldwide and helping ignite a national debate on immunization. The fallout spurred the creation of the Trusted Messenger program, which trains clinicians to listen and build trust with patients to counter misinformation as measles outbreaks prompt renewed vaccination efforts across the country.

HPV Vaccination Tied to Near-Zero Cervical Cancer Deaths in Under-30s, Study Finds
health3 months ago

HPV Vaccination Tied to Near-Zero Cervical Cancer Deaths in Under-30s, Study Finds

A Lancet analysis of English data shows girls vaccinated at age 12–13 against HPV have an almost zero risk of dying from cervical cancer before 30, with 30–34-year-olds who were vaccinated seeing a 63% lower death risk; since 2020-2024, no cervical cancer deaths were reported among 20–24-year-olds in England, and the vaccine has saved hundreds of lives. However, falling uptake (about 75% nationally, 60% in London) could reverse gains, prompting urgent action to boost vaccination and screening to help eliminate cervical cancer by 2040.

HPV Vaccine Milestone Meets New Challenge: Rising HPV-Related Cancers in Men
health4 months ago

HPV Vaccine Milestone Meets New Challenge: Rising HPV-Related Cancers in Men

Twenty years after the HPV vaccine’s approval, HPV-related cancers—especially head and neck cancers in men—are rising, even as vaccination and screening have reduced cervical cancer. HPV is transmitted sexually and can silently cause tumors in the throat, making early detection difficult. Vaccination coverage among teens is improving but remains incomplete, while studies show vaccinated individuals have significantly lower oral HPV infections and cancer risk. The piece centers on Michael Whelan’s battle with late-stage HPV-driven cancer to highlight the vaccine’s potential to prevent future cases and reduce suffering, urging broader awareness and uptake.

Five hopeful science breakthroughs reshaping health and energy
science5 months ago

Five hopeful science breakthroughs reshaping health and energy

Nature highlights five uplifting science stories from 2025–26: infants can now be treated for malaria with the weight-tailored drug artemether-lumefantrine, reducing infant deaths; six Leigh syndrome patients show mobility and breathing improvements after sildenafil (Viagra) treatment, though more trials are needed; engineered bacteria produce hydrogen from waste bread with a catalyst, cutting greenhouse-gas emissions; researchers extract hydrocarbon-rich biofuel from date-palm leaf fibers, offering a new energy source and waste-management benefit; and a US study finds HPV vaccination in boys and men linked to a 46% reduction in several cancers, underscoring the vaccine’s power for cancer prevention.

HPV vaccine cuts cancer risk for boys and men, new study shows
health5 months ago

HPV vaccine cuts cancer risk for boys and men, new study shows

A large study finds the HPV vaccine halves the risk of HPV-related cancers in men; protection is strongest when vaccinated early (about 42% reduction for ages 9–14 and about 50% for ages 15–26), with catch-up vaccination up to 26 and shared clinical decision‑making for 27–45. Public health guidance emphasizes routine vaccination at ages 11–12 to prevent cancer across sexes and expand protection against multiple HPV strains.

UK cancer deaths hit a historic low as screening and vaccines transform outcomes
health6 months ago

UK cancer deaths hit a historic low as screening and vaccines transform outcomes

UK cancer deaths fell to a record low between 2022 and 2024 (about 247 per 100,000 per year), down roughly 29% since 1989, thanks to long‑term investments in prevention, screening (notably cervical cancer) and vaccines, plus advances in treatments such as targeted therapies, hormone therapy and immunotherapy. Cervical cancer deaths have dropped dramatically due to HPV vaccination and screening; other cancers show mixed trends. While deaths are lower, total cancer deaths can still rise with an aging population, underscoring the need for continued investment in prevention, screening and research to push mortality lower.

UK cancer deaths drop to a historic low amid screening and vaccines
health7 months ago

UK cancer deaths drop to a historic low amid screening and vaccines

New data from Cancer Research UK show UK cancer deaths between 2022–2024 fell to a record low (about 247 per 100,000), down from a 1989 peak of 355 per 100,000, a ~29% decline. The drop reflects sustained investment in research, prevention, and treatments, with major gains in stomach, lung, ovarian, breast, and prostate cancers. Cervical cancer deaths have fallen 75% since the 1970s largely due to national screening and the HPV vaccine. Screening programs (cervical, breast, colorectal, PSA testing) and advances like targeted therapies and immunotherapy have improved early detection and survival. However, total deaths may still rise as the population ages. Some cancers are increasing (skin, liver, kidney) and others remain stable, but experts forecast further decreases with continued investment and screening expansion.